3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Melanoma
3
Lung Neoplasms
3
Colitis
3
Urogenital Neoplasms
2
Solid Carcinoma
2
Diarrhea
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Gastrointestinal Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Advanced Gastric Cancer
1
Interventions
venetoclax
27
fludarabine
26
Cyclophosphamide
25
Specimen Handling
21
Azacitidine
20
Biopsy
15
Whole-Body Irradiation
14
Stem Cell Transplantation
13
Decitabine
13
Cytarabine
13
Tacrolimus
12
Melphalan
12
fludarabine phosphate
11
Mycophenolic Acid
11
Busulfan
11
Injections
8
X-Rays
7
Thiotepa
7
Hematopoietic Stem Cell Transplantation
7
Granulocyte Colony-Stimulating Factor
7
decitabine and cedazuridine drug combination
6
Cyclosporine
6
ruxolitinib
5
Magnetic Resonance Spectroscopy
5
Idarubicin
5
Filgrastim
5
gilteritinib
4
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Myelodysplastic Syndromes
×
Fecal Microbiota Transplantation
×
Clear all
NCT04935684
2026-06-09
TMF-Allo
University Hospital, Clermont-Ferrand
Phase 2
Recruiting
150 enrolled